Vicagrel enhances aspirin-induced inhibition of both platelet aggregation and thrombus formation in rodents due to its decreased metabolic inactivation

Yumeng Jia, Peng‐Xin Ge, Huan Zhou, Jin‐Zi Ji, Ting Tai, Tong‐Tong Gu, Ting Zhu, Yifei Li, Qiong‐Yu Mi, Beibei Huang,

Biomedicine & Pharmacotherapy · 2019 · 12 citations · 45 references

DOIFull text

Open access

Concepts

Abstract

) and 2.8-fold increase in suppression of AA-induced platelet aggregation in mice when compared with use of aspirin alone. In the rat thrombus formation model, vicagrel (1 mg/kg) enhanced inhibition of thrombosis formation by aspirin (5 mg/kg), but not vice versa. We conclude that vicagrel increases platelet responses to aspirin and also enhances inhibition of thrombus formation of aspirin due to decreased CES2-catalyzed aspirin inactivation in rodents, and that an integrated net effect on thrombus formation in vivo is superior to inhibition of AA- or ADP-induced platelet aggregation ex vivo by either of the two drugs if taken concomitantly.

References

45